OOIR: Observatory of International Research

Papers

(The H4-Index of Viruses-Basel is 66. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)

Article	Citations
The Role of Lebanon in the COVID-19 Butterfly Effect: The B.1.398 Example	283
Altered HIV-1 Viral Copy Number and Gene Expression Profiles of Peripheral (CEM CCR5+) and Mucosal (A3R5.7) T Cell Lines Co-Infected with HSV-2 In Vitro	198
Neutralizing Antibody Response to Sarbecovirus Is Delayed in Sequential Heterologous Immunization	187
Landscape of H5 Infections in ASEAN Region: Past Insights, Present Realities, & Future Strategies	170
Pathobiology of Cutaneous Manifestations Associated with COVID-19 and Their Management	166
Phylogenetic and Phylogeographic Analysis of the Highly Pathogenic H5N6 Avian Influenza Virus in China	161
Prevalence and Spectrum of HIV-1 Resistance Mutations in the Siberian Federal District	160
Association of the p75NTR Ser205Leu Polymorphism with Asymptomatic HTLV-1 Infection	153
Monitoring the Establishment of VOC Gamma in Minas Gerais, Brazil: A Retrospective Epidemiological and Genomic Surveillance Study	148
Intramuscular [18F]F-FDG Administration for Successful PET Imaging of Golden Hamsters in a Maximum Containment Laboratory Setting	143
Comparing In Vitro Faecal Fermentation Methods as Surrogates for Phage Therapy Application	138
Longitudinal Dynamics of HPV16 Antibodies in Saliva and Serum among Pregnant Women	130
Human T-Cell Leukemia Virus Type 1-Related Diseases May Constitute a Threat to the Elimination of Human Immunodeficiency Virus, by 2030, in Gabon, Central Africa	129
Computational and Experimental Approaches to Study the RNA Secondary Structures of RNA Viruses	127
The Usefulness of the C2HEST Risk Score in Predicting Clinical Outcomes among Hospitalized Subjects with COVID-19 and Coronary Artery Disease	126
Immune-Cell-Based Therapy for COVID-19: Current Status	121
Specific Nucleotides in the Common Region of the Begomovirus Tomato Rugose Mosaic Virus (ToRMV) Are Responsible for the Negative Interference over Tomato Severe Rugose Virus (ToSRV) in Mixed Infection	119
Matrix-Encoding Gene Diversity of 624 Influenza A/H3N2 Genomes Does Not Show Association with Impaired Viral Detection by Commercialized qPCR Assays	119
Rapid System to Detect Variants of SARS-CoV-2 in Nasopharyngeal Swabs	110
Clinical and Biomarker Profile Responses to Rehabilitation Treatment in Patients with Long COVID Characterized by Chronic Fatigue	109
Kinetics of Abnormal Prion Protein in Blood of Transgenic Mice Experimentally Infected by Multiple Routes with the Agent of Variant Creutzfeldt–Jakob Disease	109
Twenty Years of Collaboration to Sort out Phage Mu Replication and Its Dependence on the Mu Central Gyrase Binding Site	108
Pseudorabies Virus Mutants Lacking US9 Are Defective in Cytoplasmic Assembly and Sorting of Virus Particles into Axons and Not in Axonal Transport	107
Neutral Impact of SARS-CoV-2 Coinfection on the Recombination-Driven Evolution of Endemic HCoV-OC43	106
Development and Application of Mouse-Derived CD2v Monoclonal Antibodies Against African Swine Fever Virus from Single B Cells	106

Genetic and Antigenic Diversity of Bubaline alphaherpesvirus 1	105
Expression and Localization of a New Parvovirus-Derived Protein in the Guinea Pig	102
Integrated Analysis of the 2022 SARS-CoV-2 Omicron Lineage Replacement Dynamics in Connecticut, US	101
Caulobacter Strains Code for Novel Restriction Endonucleases That Protect Them from Bacteriophage Infections	100
Nuclear Accumulation of Bm65 Aggregate Is Blocked by Mutations in the Nuclear Export Sequence of Bm65	99
Hepatitis B Hospitalizations in Brazil: Temporal and Regional Patterns from 2008 to 2023	99
Molecular Characterization of Emerging and Uncommon Enteroviruses C104, C105, and C109 in Respiratory Samples from Maryland, USA, 2018–2024	98
Immunogenicity and Safety Results of a Randomized, Three-Arm, Phase IV Clinical Trial of Concomitant Administration of Typhoid Vi Conjugate Vaccine with Measles and Rubella Vaccine in Healthy Infants	98
Peste des Petits Ruminants Vaccine: Criteria for Assessing Its Thermotolerance	94
Predicting COVID-19 Sepsis Outcomes: Roles of IL-6, Cardiac Biomarkers, Clinical Factors, and Vaccination Status and Exploratory Analysis of Tocilizumab Therapy in an Eastern European Cohort	94
Presence of Alphacoronavirus in Tree- and Crevice-Dwelling Bats from Portugal	92
Domestic Cat Hepadnavirus Antigens in Lymphoma Tissues. Comment on Beatty et al. Domestic Cat Hepadnavirus and Lymphoma. Viruses 2023, 15, 2294	91
Adjustment of Immunosuppressants to Facilitate Anti-COVID-19 Antibody Production after mRNA Vaccination in Liver Transplant Recipients	88
Emerging Viral Infections in Pregnancy: What’s New in 2022?	88
Utility of ISARIC 4C Mortality Score, Vaccination History, and Anti-S Antibody Titre in Predicting Risk of Severe COVID-19	87
Semi-Covariance Coefficient Analysis of Spike Proteins from SARS-CoV-2 and Its Variants Omicron, BA.5, EG.5, and JN.1 for Viral Infectivity, Virulence and Immune Escape	85
Evaluation of Bispecific T-Cell Engagers Targeting Murine Cytomegalovirus	85
Pathogenic and Apathogenic Strains of Lymphocytic Choriomeningitis Virus Have Distinct Entry and Innate Immune Activation Pathways	84
Gender-Responsive Design of Bacteriophage Products to Enhance Adoption by Chicken Keepers in Kenya	83
T Cells in Tick-Borne Flavivirus Encephalitis: A Review of Current Paradigms in Protection and Disease Pathology	82
Fucose Binding Cancels out Mechanical Differences between Distinct Human Noroviruses	82
Anti-SARS-CoV-2 Titers Predict the Severity of COVID-19	82
SARS-CoV-2 Delta Variant N Gene Mutations Reduce Sensitivity to the TaqPath COVID-19 Multiplex Molecular Diagnostic Assay	82
LSDV-Vectored SARS-CoV-2 S and N Vaccine Protects against Severe Clinical Disease in Hamsters	80
No Time to Die: How Cytomegaloviruses Suppress Apoptosis, Necroptosis, and Pyroptosis	80
Cocktail, a Computer Program for Modelling Bacteriophage Infection Kinetics	76
ScRNA-Seq and BCR Analysis of Murine Immune Responses to Inactivated DHAV-1 as a Model Antigen	75
Human Prion Disease: Pathogenesis, Diagnosis and Public Health	75
Early or Simultaneous Infection with Infectious Pancreatic Necrosis Virus Inhibits Infectious Hematopoietic Necrosis Virus Replication and Induces a Stronger Antiviral Response during Co-infection in	74
Genomic Characterization and Evolutionary Dynamics of SARS-CoV-2 Lineage NB.1.8.1 in Thailand, 2025	73
Molnupiravir Inhibits Porcine Epidemic Diarrhea Virus Infection In Vitro	73
Australian Cool-Season Pulse Seed-Borne Virus Research: 1. Alfalfa and Cucumber Mosaic Viruses and Less Important Viruses	73
Grapevine Virome of the Don Ampelographic Collection in Russia Has Concealed Five Novel Viruses	73
Canine Distemper Virus in Mexico: A Risk Factor for Wildlife	73
Engineered Resistance to Tobamoviruses	70
Host Barriers Limit Viral Spread in a Spillover Host: A Study of Deformed Wing Virus in the Bumblebee Bombus terrestris	70
Molecular Evolution and Phylogeography of the Crimean–Congo Hemorrhagic Fever Virus	67
Variability in the Clinical Course of COVID-19 in a Retrospective Analysis of a Large Real-World Database	67
Seroprevalence of SARS-CoV-2 IgG Antibodies and Factors Associated with SARS-CoV-2 IgG Neutralizing Activity among Primary Health Care Workers 6 Months after Vaccination Rollout in France	66
Elimination of Solanum nigrum ilarvirus 1 and Apple Hammerhead Viroid from Apple Cultivars Using Antivirals Ribavirin, Rimantadine, and Zidovudine	66
Prediction of Clinical Trajectory in HCV-Related ACLD after SVR: Role of Liver Stiffness in a 5-Years Prospective Study	66